AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.890
-0.140 (-3.47%)
Jul 8, 2025, 4:00 PM - Market closed
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.16 billion as of July 8, 2025. Its market cap has increased by 34.31% in one year.
Market Cap
1.16B
Enterprise Value
623.69M
1-Year Change
34.31%
Ranking
Category
Stock Price
$3.89
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.16B, a decrease of -92.59%. That is a compound annual growth rate of -43.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2025 | 1.16B | 34.17% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.83B |
| Johnson & Johnson | 373.59B |
| AbbVie | 331.43B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 275.51B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.62B |
| AstraZeneca | 216.19B |